Clinical Trial

Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response

Study acronym: PLP-EVEREST
Recruiting
View on ClinicalTrials.gov →
Summary
The investigators have designed a pragmatic trial of home-based transcranial direct current stimulation (tDCS) for phantom limb pain (PLP), the PLP-EVEREST trial (PLP-EffectiVEness pRagmatic Stimulation Trial) to test a portable device that would reach underrepresented populations and would validate this therapy in a more pragmatic setting. Subjects will be randomized to home-based tDCS of the primary motor cortex (M1) with somatosensory training or usual care only (including their current pharmacological treatments, physical therapy, and occupational therapy). The investigators will therefore test the effectiveness of home-based tDCS and somatosensory training in a real-world, home-based setting. The Investigator will compare patients randomized to this combined strategy vs. usual care alone (subjects from this group will be offered combined treatment at the end of the trial). The investigators hypothesize that the combined strategy will be associated with a significantly larger Cohen's d effect size (at least 1) compared to the control group.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-01-10; most recent amendment 2025-09-15.
Status change: Not Yet Recruiting → Recruiting 2023-01-13
Status change: Withheld → Not Yet Recruiting 2022-06-14
Trial Details
NCT Number NCT05188183
Lead Sponsor Spaulding Rehabilitation Hospital
Conditions Phantom Limb Pain
Enrollment 290 participants
Start Date 2022-09-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-19